View in EDS PDF Full Text

Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.

Saved in:
Bibliographic Details
Title: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
Authors: Asaduzzaman M; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.; Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, 1000, Bangladesh., Constantinou S; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.; MRC Cancer Unit, Hutchison/MRC Research Centre, Cambridge, CB2 0XZ, UK., Min H; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK., Gallon J; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK., Lin ML; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK., Singh P; Centre for Pathology, Department of Medicine, Imperial College Faculty of Medicine, Charing Cross Hospital, Fulham Palace Rd, London, W6 8RF, UK., Raguz S; Division of Clinical Sciences, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK., Ali S; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK., Shousha S; Centre for Pathology, Department of Medicine, Imperial College Faculty of Medicine, Charing Cross Hospital, Fulham Palace Rd, London, W6 8RF, UK., Coombes RC; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK., Lam EW; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK., Hu Y; The 3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Huan Hu Xi Road, Ti Yuan Bei, He xi District, Tianjin, 300060, People's Republic of China. 417501784@qq.com., Yagüe E; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. ernesto.yague@imperial.ac.uk.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Jun; Vol. 163 (3), pp. 461-474. Date of Electronic Publication: 2017 Mar 24.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28341962
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Asaduzzaman+M%22">Asaduzzaman M</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.; Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, 1000, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Constantinou+S%22">Constantinou S</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.; MRC Cancer Unit, Hutchison/MRC Research Centre, Cambridge, CB2 0XZ, UK.<br /><searchLink fieldCode="AU" term="%22Min+H%22">Min H</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.<br /><searchLink fieldCode="AU" term="%22Gallon+J%22">Gallon J</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.<br /><searchLink fieldCode="AU" term="%22Lin+ML%22">Lin ML</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.<br /><searchLink fieldCode="AU" term="%22Singh+P%22">Singh P</searchLink>; Centre for Pathology, Department of Medicine, Imperial College Faculty of Medicine, Charing Cross Hospital, Fulham Palace Rd, London, W6 8RF, UK.<br /><searchLink fieldCode="AU" term="%22Raguz+S%22">Raguz S</searchLink>; Division of Clinical Sciences, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.<br /><searchLink fieldCode="AU" term="%22Ali+S%22">Ali S</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.<br /><searchLink fieldCode="AU" term="%22Shousha+S%22">Shousha S</searchLink>; Centre for Pathology, Department of Medicine, Imperial College Faculty of Medicine, Charing Cross Hospital, Fulham Palace Rd, London, W6 8RF, UK.<br /><searchLink fieldCode="AU" term="%22Coombes+RC%22">Coombes RC</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.<br /><searchLink fieldCode="AU" term="%22Lam+EW%22">Lam EW</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.<br /><searchLink fieldCode="AU" term="%22Hu+Y%22">Hu Y</searchLink>; The 3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Huan Hu Xi Road, Ti Yuan Bei, He xi District, Tianjin, 300060, People's Republic of China. 417501784@qq.com.<br /><searchLink fieldCode="AU" term="%22Yagüe+E%22">Yagüe E</searchLink>; Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. ernesto.yague@imperial.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2017 Jun; Vol. 163 (3), pp. 461-474. <i>Date of Electronic Publication: </i>2017 Mar 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28341962
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-017-4202-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 461
    Titles:
      – TitleFull: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Asaduzzaman M
      – PersonEntity:
          Name:
            NameFull: Constantinou S
      – PersonEntity:
          Name:
            NameFull: Min H
      – PersonEntity:
          Name:
            NameFull: Gallon J
      – PersonEntity:
          Name:
            NameFull: Lin ML
      – PersonEntity:
          Name:
            NameFull: Singh P
      – PersonEntity:
          Name:
            NameFull: Raguz S
      – PersonEntity:
          Name:
            NameFull: Ali S
      – PersonEntity:
          Name:
            NameFull: Shousha S
      – PersonEntity:
          Name:
            NameFull: Coombes RC
      – PersonEntity:
          Name:
            NameFull: Lam EW
      – PersonEntity:
          Name:
            NameFull: Hu Y
      – PersonEntity:
          Name:
            NameFull: Yagüe E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2017 Jun
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 163
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1